Completed NA INTERVENTIONAL 2-arm NCT02157246

RHYTHM-I: Investigating Hypoxia in Rectal Tumours (RHYTHM-I)

RHYTHM-I: Modulation of Radiotherapy According to HYpoxia: Exploiting Changes in the Tumour Microenvironment to Improve Outcome in Rectal Cancer.

Sponsor: University of Oxford

Conditions Hypoxia in Rectal Cancer

Interventions Biopsy Blood sample F-MISO PET Functional MRI Pimonidazole pCT

Updated 7 times since 2017 Last updated: Mar 8, 2017 Started: Oct 31, 2013 Primary completion: Nov 30, 2016 Completion: Nov 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Hypoxia in Rectal Cancer and is currently completed. University of Oxford leads this study, which shows 7 recorded versions since 2013 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
May 2017 — Jun 2018 [monthly]

Completed NA

Phase: EARLY_PHASE1 → NA

▶ Show 2 earlier versions

Feb 2017 — May 2017 [monthly]

Completed EARLY_PHASE1

Status: Active Not Recruiting → Completed · Phase: Phase 0 → EARLY_PHASE1
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting Phase 0

First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Oxford

Data source: University of Oxford

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oxford, United Kingdom